Concepedia

Daniel E. Lopes de Menezes

DE

10

Publications

889

Citations

10

H-Index

1995

Active since

Affiliations

University of Alberta(Current)

Novartis (United States)

University of British Columbia

Daniel E. Lopes de Menezes is an author at University of Alberta specializing in immunotherapy, immunology, and medicine.

Top concepts

Publications per year

1995–2007

10

Publications

10

Pharmacokinetics of long-circulating liposomes

Theresa M. Allen, Christian Hansen, Daniel E. Lopes de Menezes · Advanced Drug Delivery Reviews · 1995 · 300 citations

, , +2

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i>

Archie Tse, Katherine G. Rendahl, Tahir Sheikh et al. · Clinical Cancer Research · 2007 · 149 citations

CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia

Daniel E. Lopes de Menezes, Jing Peng, Evelyn N. Garrett et al. · Clinical Cancer Research · 2005 · 111 citations · Full text

Long-circulating, polyethylene glycol-grafted immunoliposomes

Samuel Zalipsky, Christian Hansen, Daniel E. Lopes de Menezes et al. · Journal of Controlled Release · 1996 · 73 citations

, , +4

Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells

Daniel E. Lopes de Menezes, Marc Kirchmeier, Jean-François Gagné et al. · Journal of Liposome Research · 1999 · 71 citations

, , +16

Rows per page

1–5 of 10